Evaluation of the relationship between IgE level and skin superinfection in children with atopic dermatitis

Allergy and Asthma Proceedings

Volumn 31, Issue 3, 2010, Pages 232-237

  Simpson, Alyson B ^a   Yousef, Ejaz ^a   Hossain, Jobayer ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Allergic rhinitis; Asthma; Atopic dermatitis; Dust mite allergen; Food allergy; IgE level; Peanut allergy; Skin superinfection; Staphylococcus aureus; Steroid cream

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN E; STEROID;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ATOPIC DERMATITIS; CELL POLARITY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALIDITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TH2 CELL; WILCOXON SIGNED RANKS TEST;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; INFANT; RETROSPECTIVE STUDIES; RISK; SKIN; STAPHYLOCOCCAL INFECTIONS; SUPERINFECTION; TH1-TH2 BALANCE;

EID: 77953796006     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3335     Document Type: Article

References (30)

1. Leung DYM, Tharp M, and Boguniewicz M. Atopic dermatitis (atopic eczema). In Fitzpatrick's Dermatology in General Medicine, 5th ed., Vol. 1. Freedberg IM, Eisen AZ, Wolff K, et al. (Eds). New York: McGraw-Hill, 1464-1480, 1998.
2. Leyden JJ, Marples RR, and Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90:525-530, 1974.
3. Breuer K, Haussler S, Kapp A, et al. Staphylococcus aureus: Colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 147:55-61, 2002.
4. Breuer K, Wittmann M, Bösche B, et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 55:551-555, 2000.
5. Levy R, Gelfand JM, Yan AC. The epidemiology of atopic dermatitis. Clin Dermatol 21:109-115, 2003.
6. Gilani SJ, Gonzalez M, Hussain I, et al. Staphylococcus aureus re-colonization in atopic dermatitis: Beyond the skin. Clin Exp Dermatol 30:10-13, 2005.
7. Breuer K, Wittmann M, Bösche B, et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 55:551-555, 2000.
8. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases. J Am Acad Dermatol 49:198-205, 2003. (Pubitemid 36951264)
9. Ali RS, Falconer A, Ikram M, et al. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 117:106-111, 2001. (Pubitemid 32652446)
10. McGirt LY, and Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol 118:202-208, 2006. (Pubitemid 43946481)
11. Reinhold U, Wehrmann W, Kukel S, et al. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 79:374-379, 1990. (Pubitemid 20082263)
12. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120:150-155, 2007. (Pubitemid 46990506)
13. Leung DY. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol 124:494-495, 2009.
14. Howell MD, Gallo RL, Boguniewicz M, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-348, 2006.
15. Kisich KO, Howell MD, Boguniewicz M, et al. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127:2368-2380, 2007.
16. Dorschner RA, Pestonjamasp VK,Tamakuwala S, et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-97, 2001.
17. Gallo RL, and Huttner KM. Antimicrobial peptides: An emerging concept in cutaneous biology. J Invest Dermatol 111:739-743, 1998.
18. Fearon DT, and Locksley RM. The instructive role of the innate immunity in the acquired immune response. Science 272:50-53, 1996.
19. Blanpain C, and Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22:339-373, 2006.
20. Kisich KO, Carspecken CW, Fiéve S, et al. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human b-defensin-3. J Allergy Clin Immunol 122:62-68, 2008.
21. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet 351:1225-1232, 1998.
22. Stensen L, Thomsen SF, and Backer V. Change in prevalence of atopic dermatitis between 1986 and 2001 among children. Allergy Asthma Proc 29:392-396, 2008.
23. Joshi AY, Iyer VN, Boyce TG, et al. Elevated serum immunoglobulin E (IgE): When to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience. Allergy Asthma Proc 30:23-27, 2009.
24. Warner JA, McGirt LY, and Beck LA. Biomakers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis. Br J Dermatol 160:183-185, 2009.
25. Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 127:1261-1263, 2007. (Pubitemid 46625135)
26. Hanifin JM, and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 92:44-47, 1980.
27. Klink M, Cline MG, Halonen M, et al. Problems in defining normal limits for serum IgE. J Allergy Clin Immunol 85:440-444, 1990. (Pubitemid 20075180)
28. Erwin EA, Rönmark E, Wickens K, et al. Contribution of dust mite and cat specific IgE to total IgE: Relevance to asthma prevalence. J Allergy Clin Immunol 119:359-365, 2007. (Pubitemid 46204826)
29. He R, Kim HY, Yoon J, et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol 124:761-1770, 2009.
30. Eyerich K, Pennino D, Scarponi C, et al. IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clinical Immunol 123:59-66, 2009.